Coronavirus: Ortho Clinical Diagnostics CEO explains the company's antibody test

preview_player
Показать описание
Ortho Clinical Diagnostic announced over the weekend it is bringing an automated blood test for coronavirus to the markets in a matter of weeks. The testing kit detects antibodies for COVID-19 that can be used to detect immune response to the virus. Chris Smith, CEO of Ortho Clinical Diagnostic, joins "Squawk Box" by phone to discuss.

Research to develop vaccines and treatments to fight the coronavirus has “accelerated at incredible speed,” World Health Organization Director-General Dr. Tedros Adhanom Ghebreyesus said Monday.

He said more than 70 countries have joined WHO’s trial to accelerate research on effective treatments and “about 20 institutions and companies are racing to develop a vaccine.”

“The viral genome was mapped in early January and shared globally which enabled tests to be developed and vaccine research to start,” Tedros said at a news conference at WHO headquarters in Geneva.

For more coronavirus live updates:

For access to live and exclusive video from CNBC subscribe to CNBC PRO:


Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

Connect with CNBC News Online

#CNBC
#CNBC TV
Рекомендации по теме
Комментарии
Автор

Areas of Availability: college campuses along with geo areas & HC systems are all good candidates. Does the blood test pick up & ID a spectrum of antibodies? IgG mentioned.. IgM IgE IgA.. others? Thank you for this segment. 👍🏻

HeyMJ.